Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis

By Keever-Taylor Ca   Browning Mb   Johnson Bd   Truitt Rl   Bredeson Cn   Behn B.   Tsao A.  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 144-157

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy

By Sumida Y.   Nakamura K.   Kanayama K.   Akiho H.   Teshima T.   Takayanagi R.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 698-710

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD4+ CD25+ regulatory T cells approach the clinic

By Edinger M.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 655-656

Ashgate Publishing Ltd

Access to resources Recommend Favorite

T-Cell Depletion of Allogeneic Bone Marrow Grafts: Enrichment of Mononuclear Cells Using the COBE Spectra Cell Processor, Followed by Immunoselection of CD34⁺ Cells

By Olivero S   Novakovitch G   Ladaique P   Sainty D   Viret F   Faucher C   Stoppa AM   Blaise D   Chabannon C  

Cytotherapy, Vol. 1, Iss. 6, 1999-01 ,pp. : 469-477

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Impact on T-cell depletion and CD34⁺ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G

By Williams R.J.   Clarke E.   Blair A.   Evely R.   Hale G.   Waldmann H.   Brookes S.   Pamphilon D.H.  

Cytotherapy, Vol. 2, Iss. 1, 2000-01 ,pp. : 5-14

Ashgate Publishing Ltd

Access to resources Recommend Favorite